DEMUTH TIM (Chief Medical Officer) purchased 6K shares of PALVELLA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $10.3K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/16/2022ACC: 0001583648-22-000030
Officer· Chief Medical Officer
Since Aug 2021
+6K
Net shares
Net buyer
$10.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6K
Price / share
$1.71
Trade value
$10.26K
% of position
New position
5/13/2022
0.00→6K
Total
Net shares
+6K
Net value
$10.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2022 | P · Purchase | +6K | $1.71 | $10.26K | New position | 0.00 | 6K |
| Total | +6K | $10.26K | ||||||
Derivative Transactions0
No derivative transactions reported